Unaudited standalone and consolidated financial results for the period ended Jun 30, 2026
As filed · Shilpa Medicare Limited has submitted to the Exchange, the Unaudited standalone and consolidated financial results for the period ended Jun 30, 2026.
What happened
FactShilpa Medicare Limited's Board of Directors approved the un-audited financial results for the quarter ended 30th June 2026 and appointed Mr. Sharath Reddy Kalakota as a Whole Time Director, subject to approval at the upcoming Annual General Meeting (AGM). The company plans to invest up to EUR 7 million in Gate2Brain through its subsidiary, Shilpa Biocare Private Limited. The 39th AGM is scheduled for 11th September 2026, and the record date for determining shareholders…
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
DelayedWe will try to monetize all these investments.
We should be doing another about INR75 crores to INR100 crores from here on.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- So we are expecting to start our clinical study, Phase III clinical study, in Q4 FY '26. (management committed by Q4 FY26)
- We should be doing another about INR75 crores to INR100 crores from here on. (management committed by FY26)
Evidence
- Shilpa Medicare Limited has submitted to the Exchange, the Unaudited standalone and consolidated financial results for the period ended Jun 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q2 FY26
- Latest statement · Q2 FY26
- Earlier statement · Q2 FY26
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +6 corroborating keywords; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%